{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T19:54:13Z","timestamp":1789761253304,"version":"4.0.1"},"reference-count":24,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2014,4,1]],"date-time":"2014-04-01T00:00:00Z","timestamp":1396310400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["ijaaonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2014,4]]},"DOI":"10.1016\/j.ijantimicag.2013.12.002","type":"journal-article","created":{"date-parts":[[2013,12,15]],"date-time":"2013-12-15T14:00:53Z","timestamp":1387116053000},"page":"349-352","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":126,"title":["Risk factors for acute kidney injury in patients treated with polymyxin B or colistin methanesulfonate sodium"],"prefix":"10.1016","volume":"43","author":[{"given":"Felipe F.","family":"Tuon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Helena","family":"Rigatto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cesar K.","family":"Lopes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Let\u00edcia K.","family":"Kamei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaime L.","family":"Rocha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre P.","family":"Zavascki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2013.12.002_bib0005","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1093\/jac\/dkm357","article-title":"Polymyxin B for the treatment of multidrug-resistant pathogens: a critical review","volume":"60","author":"Zavascki","year":"2007","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2013.12.002_bib0010","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1592\/phco.30.12.1279","article-title":"Resurgence of colistin: a review of resistance, toxicity, pharmacodynamics, and dosing","volume":"30","author":"Lim","year":"2010","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.ijantimicag.2013.12.002_bib0015","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.diagmicrobio.2012.07.010","article-title":"Pharmacokinetics and pharmacodynamics of \u2018old\u2019 polymyxins: what is new?","volume":"74","author":"Bergen","year":"2012","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.ijantimicag.2013.12.002_bib0020","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1086\/599225","article-title":"Nephrotoxicity associated with intravenous colistin (colistimethate sodium) treatment at a tertiary care medical center","volume":"48","author":"Hartzell","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2013.12.002_bib0025","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.ijantimicag.2009.12.002","article-title":"Predictors of acute kidney injury associated with intravenous colistin treatment","volume":"35","author":"Kwon","year":"2010","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2013.12.002_bib0030","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1592\/phco.31.12.1257","article-title":"Nephrotoxicity associated with intravenous colistin in critically ill patients","volume":"31","author":"Doshi","year":"2011","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.ijantimicag.2013.12.002_bib0035","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1093\/cid\/cir611","article-title":"Incidence of and risk factors for colistin-associated nephrotoxicity in a large academic health system","volume":"53","author":"Pogue","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2013.12.002_bib0040","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.jinf.2012.01.015","article-title":"Incidence and predictors of acute kidney injury associated with intravenous polymyxin B therapy","volume":"65","author":"Kubin","year":"2012","journal-title":"J Infect"},{"key":"10.1016\/j.ijantimicag.2013.12.002_bib0045","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1093\/cid\/cit453","article-title":"Higher incidence of acute kidney injury with intravenous colistimethate sodium compared with polymyxin B in critically ill patients at a tertiary care medical center","volume":"57","author":"Akajagbor","year":"2013","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2013.12.002_bib0050","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1002\/phar.1271","article-title":"Emergent renal dysfunction with colistin pharmacotherapy","volume":"33","author":"Collins","year":"2013","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.ijantimicag.2013.12.002_bib0055","doi-asserted-by":"crossref","first-page":"R174","DOI":"10.1186\/cc12853","article-title":"Risk factors for acute kidney injury in critically ill patients receiving high intravenous doses of colistin methanesulfonate and\/or other nephrotoxic antibiotics: a retrospective cohort study","volume":"17","author":"Rocco","year":"2013","journal-title":"Crit Care"},{"key":"10.1016\/j.ijantimicag.2013.12.002_bib0060","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1186\/1471-2334-13-380","article-title":"Trough colistin plasma level is an independent risk factor for nephrotoxicity: a prospective observational cohort study","volume":"13","author":"Sorli","year":"2013","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.ijantimicag.2013.12.002_bib0065","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1093\/cid\/cis909","article-title":"Association between colistin dose and microbiologic outcomes in patients with multidrug-resistant Gram-negative bacteremia","volume":"56","author":"Vicari","year":"2013","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2013.12.002_bib0070","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.diagmicrobio.2009.07.018","article-title":"Polymyxin B and colistimethate are comparable as to efficacy and renal toxicity","volume":"65","author":"Oliveira","year":"2009","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.ijantimicag.2013.12.002_bib0075","doi-asserted-by":"crossref","first-page":"R31","DOI":"10.1186\/cc5713","article-title":"Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury","volume":"11","author":"Mehta","year":"2007","journal-title":"Crit Care"},{"key":"10.1016\/j.ijantimicag.2013.12.002_bib0080","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1053\/j.ajkd.2013.02.349","article-title":"KDOQI US commentary on the 2012 KDIGO clinical practice guideline for acute kidney injury","volume":"61","author":"Palevsky","year":"2013","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.ijantimicag.2013.12.002_bib0085","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J Chronic Dis"},{"key":"10.1016\/j.ijantimicag.2013.12.002_bib0090","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.ajic.2008.03.002","article-title":"CDC\/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting","volume":"36","author":"Horan","year":"2008","journal-title":"Am J Infect Control"},{"key":"10.1016\/j.ijantimicag.2013.12.002_bib0095","doi-asserted-by":"crossref","first-page":"2392","DOI":"10.1128\/AAC.00028-12","article-title":"Incidence and predictors of nephrotoxicity associated with intravenous colistin in overweight and obese patients","volume":"56","author":"Gauthier","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2013.12.002_bib0100","doi-asserted-by":"crossref","first-page":"R16","DOI":"10.1186\/cc9960","article-title":"Clinical accuracy of RIFLE and Acute Kidney Injury Network (AKIN) criteria for acute kidney injury in patients undergoing cardiac surgery","volume":"15","author":"Englberger","year":"2011","journal-title":"Crit Care"},{"key":"10.1016\/j.ijantimicag.2013.12.002_bib0105","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.jcrc.2012.12.008","article-title":"Acute kidney injury after cardiac surgery according to Risk\/Injury\/Failure\/Loss\/End-stage, Acute Kidney Injury Network, and Kidney Disease: Improving Global Outcomes classifications","volume":"28","author":"Bastin","year":"2013","journal-title":"J Crit Care"},{"key":"10.1016\/j.ijantimicag.2013.12.002_bib0110","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1093\/jac\/dkq285","article-title":"The impact of polymyxin B dosage on in-hospital mortality of patients treated with this antibiotic","volume":"65","author":"Elias","year":"2010","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2013.12.002_bib0115","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.ijantimicag.2009.10.005","article-title":"Colistin therapy for microbiologically documented multidrug-resistant Gram-negative bacterial infections: a retrospective cohort study of 258 patients","volume":"35","author":"Falagas","year":"2010","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2013.12.002_bib0120","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1093\/cid\/cis286","article-title":"High-dose, extended-interval colistin administration in critically ill patients: is this the right dosing strategy? A preliminary study","volume":"54","author":"Dalfino","year":"2012","journal-title":"Clin Infect Dis"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857913003919?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857913003919?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,8]],"date-time":"2018-10-08T05:55:17Z","timestamp":1538978117000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857913003919"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4]]},"references-count":24,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,4]]}},"alternative-id":["S0924857913003919"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2013.12.002","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2014,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risk factors for acute kidney injury in patients treated with polymyxin B or colistin methanesulfonate sodium","name":"articletitle","label":"Article Title"},{"value":"International Journal of Antimicrobial Agents","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2013.12.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier B.V. and the International Society of Chemotherapy. All rights reserved.","name":"copyright","label":"Copyright"}]}}